Fintech PR
Aurisco gets Auxiton® (Dydrogesterone) as first generic approval in China
SHANGHAI, June 27, 2023 /PRNewswire/ — Aurisco Pharmaceutical has good reasons to celebrate. On its 25th anniversary, the high-tech pharmaceutical company dedicated to innovation has received its first Marketing Authorization Approval in China for AUXITON®, the oral finished dosage form of Dydrogesterone, from China’s Health Authority, the NMPA. Aurisco is the only company holding both an active USDMF and a valid CEP – the Certificate of compliance with the European Pharmacopoeia, issued by the EDQM for the drug substance.
Aurisco’s Chairman and founder, Mr. Peng Zhien, said: “After getting listed at the Shanghai Stock Exchange in 2020, this approval is another very important milestone for Aurisco. However, this is even more important for women with certain medical conditions that prevent them from having a healthy and successful pregnancy. These patients were the driving force for Aurisco to integrate the manufacturing of the active pharmaceutical ingredient with the development and manufacturing of the oral tablet finished dosage form. We hope to contribute to the happiness of many couples, by making possible their dream of having a baby.”
As explained by Vivian Shan, MD, Aurisco Pharmaceutical’s Medical Manager for this program, “AUXITON® provides doctors a safe and convenient, orally bioavailable dydrogesterone – a highly selective progestogen receptor agonist. With an equivalence dose 10–20 times lower than progesterone due to its better bioavailability and the progestogenic nature of the metabolites, dydrogesterone has multiple advantages over natural progesterone, ensuring efficacy and safety to establish the adequate levels for luteal support during natural pregnancy and in-vitro fertilization (IVF).”
“Since its foundation, Aurisco has been developing complex generic molecules, including steroids like dydrogesterone and more recently peptides like semaglutide or oligonucleotides such as nusinersen. Integrating the production of API, formulation and finished dosage, Aurisco ensures product quality, productivity, and cost advantages throughout the entire industrial chain, to guarantee adequate productivity and stable supply to meet new clinical programs. Following international cGMP and EHS standards, our product quality is in line with China, Europe, and United States standards. We have been working with the best generic pharmaceutical companies in the world, supplying them safe, sustainable, affordable and high-quality products. Leveraging on our technologically advanced and differentiated capabilities, we also work with innovators, offering contract research, development and manufacturing services (CRDMO),” says Alessandro Ricci, President of Aurisco USA, based in New York.
Rafael Antunes, Aurisco’s Vice-President for Business Development in Europe, stated: “The company has always been a pioneer in the API space. We were the first company in China to develop the phytosterol technology or to pass a RX360 supply-chain security audit. Being Ecovadis ranked, we have embraced ESG and Sustainability, by joining the Science Based Targets initiative (SBTi), the Manufacture 2030 and Energize initiatives to decarbonize the pharmaceutical supply-chain and adopt renewable energies, just to mention a few. We are based in China but export to over 100 countries, so we have a global responsibility.”
“The development and manufacturing of AUXITON® is a good example of some of our technical capabilities. As a science-based company, we have developed recombinant strains for fermentation, we produce and use selective enzymes for biocatalysis and chiral catalysts for asymmetric hydrogenation or industrial-scale photochemistry to make processes more sustainable and economical. Our dydrogesterone is produced with very low impurity levels, with consistent pharmacokinetic and human bioequivalence profiles when compared with the originator, essential prerequisites for clinical efficacy and safety. We are fast, very innovative and work with the best Universities to attract and retain top talent in the company. Aurisco has filled over 80 patents worldwide and offer customers the confidence of a IP-safe partner in China,” said Prof. Li Jinliang, CEO of Aurisco’s Biotech subsidiary, in Shanghai.
To learn more about Aurisco Pharmaceutical and its products and CRDMO services, please contact [email protected].
About Dydrogesterone
Dydrogesterone is a potent orally active progesterone receptor agonist that was developed in the 1950s and that has been widely used since the 1960s for menstrual disorders such as premenstrual syndrome, cycle irregularity, endometriosis, threatened miscarriage, and habitual miscarriage, and for postmenopausal hormone therapy. It is estimated that the cumulative exposure for all indications from 1960–2017 is >113 million patients.
About Aurisco Pharmaceutical
Aurisco Pharmaceutical is a listed company on the Shanghai Stock Exchange (Stock code: 605116). With 25 years of experience in the development and manufacturing of complex APIs for regulated markets and with 6 R&D centers and 3 cGMP inspected manufacturing sites, it is focused on semi-synthetic and synthetic APIs, including steroids, peptides and oligonucleotides and hormone-based finished dosage forms, offering CRDMO services to the Global Pharmaceutical Industry.
Logo – https://mma.prnewswire.com/media/2142124/Aurisco_25th_Anniversary_Logo.jpg
Media contact:
Rafael Antunes
[email protected]
+351 919 387 143
View original content:https://www.prnewswire.co.uk/news-releases/aurisco-gets-auxiton-dydrogesterone-as-first-generic-approval-in-china-301864901.html
View original content:
Fintech PR
WSPN Partners with Viction and Ninety Eight Ecosystem to Boost WUSD Adoption and Expand Market Reach
SINGAPORE, Nov. 5, 2024 /PRNewswire/ — Worldwide Stablecoin Payment Network (WSPN) is excited to announce a strategic partnership with Viction, a global Layer-1 blockchain that empowers builders at every level through accessible and scalable infrastructure, along with holistic guidance. In collaboration with the Ninety Eight (formerly known as Coin98) ecosystem, this partnership aims to expand WUSD’s reach, strengthening its role as a stable and accessible digital asset across the evolving Web3 landscape. Together, WSPN, Viction, and Ninety Eight will enhance interoperability, boost liquidity, and drive local market adoption, with a strong focus on growth in emerging markets.
Expanding WUSD as a Native Stablecoin on Viction
WSPN will deploy WUSD natively on Viction, supporting integration across Web3 applications and enhancing liquidity for users and developers. With WUSD as a core asset, Viction’s ecosystem will foster secure, stable transactions, empowering dApps, protocols, and platforms with increased interoperability and cross-chain functionality.
Market Expansion, CEX Listings, and Joint Community Outreach
To expand WUSD’s presence in Vietnam, Viction will tap into its resources alongside the Ninety Eight ecosystem to drive local adoption through strategic partnerships and collaborative community outreach. Listing WUSD on major centralized exchanges will increase accessibility, reaching a broader audience. This joint effort benefits both WSPN and Viction, with WUSD enhancing visibility for Viction’s technology and ecosystem, while Viction’s strong local network and Ninety Eight’s established connections boost WUSD’s growth. Through initiatives like webinars, ambassador programs, and developer workshops, the partnership will engage the community and build a lasting foundation, fostering an understanding of both WUSD’s value and Viction’s strengths.
Collaborative Responsibilities and Support
WSPN will oversee WUSD’s deployment on Viction and foster collaborations within its ecosystem, while Ninety Eight and Viction will support liquidity management, integrating WUSD into the Coin98 Super Wallet and strengthening infrastructure to ensure effective interoperability. Marketing initiatives led by WSPN and Viction will drive awareness and engagement for both ecosystems, reaching institutional audiences and building lasting adoption across the region.
Together, WSPN, Viction, and Ninety Eight are setting a new standard for collaboration in the Web3 space: Uniting technology, community, and accessibility to create a robust ecosystem. By empowering local markets and driving sustainable growth, this partnership is paving the way for a more inclusive, innovative blockchain future. The journey is only beginning, and the potential is limitless.
About WSPN
WSPN is a leading provider of next-generation stablecoin infrastructure, committed to building a more secure, efficient, and transparent payment solution for the global economy. Their flagship product, WUSD stablecoin, is pegged 1:1 to the U.S. Dollar and aims to optimize secure digital payments for Web3 users. WSPN ‘s Stablecoin 2.0 approach prioritizes user-centricity, community governance, and accessibility, paving the way for widespread stablecoin adoption.
Learn more: www.wspn.io | X | LinkedIn
About Viction
Viction is a global layer-1 blockchain that empowers builders at every level, provides both the foundation and enhancements necessary for projects to achieve stability and soar to their higher selves.
Viction provides seamless interoperability, scalability, flexible development, zero gas fees, enhanced security, and speed to enable builders with tech capabilities.
Beyond technical advantages, Viction offers holistic guidance through consultation, resources, funding, and strong network connections to foster project growth.
About Ninety Eight
Ninety Eight is an ecosystem of innovation companies with a shared mission to enable and empower human potential. They found and fund blockchain companies that make Web3 accessible for everyone.
Logo – https://mma.prnewswire.com/media/2429245/WSPN_logo_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/wspn-partners-with-viction-and-ninety-eight-ecosystem-to-boost-wusd-adoption-and-expand-market-reach-302296318.html
Robust performance in challenging markets; volumes stabilising
ZURICH, Nov. 5, 2024 /PRNewswire/ —
- Revenues -5% yoy organic TDA, -3% yoy organic, a solid result given market conditions, high comparison base; volumes stabilising
- By GBU, Adecco -5%, with good results across Asia, Iberia, EEMENA, LatAm outweighed by challenging markets, particularly in France, US; Akkodis -5%, with Consulting +2%; LHH -7%, with Recruitment Solutions stable qoq
- Resilient 19.4% gross margin, sequentially flat, reflecting lower volumes, current business mix, firm pricing
- SG&A expenses improved to €925 million, -5% yoy, with G&A -10% yoy and at 3.2% of revenues
- Robust 3.3% EBITA margin, reflecting strong G&A savings, selective protection of sales and delivery capacity
- Operating income €162 million; Net income €99 million; Basic EPS €0.59; Adjusted EPS €0.68
- Operating cash flow +€121 million, weighed by timing differences; Free cash flow +€117 million YTD, higher yoy
- Continued delivery of Simplify-Execute-Grow agenda:
- G&A savings run-rate end-24 lifted to €171 million
- Reprioritised IT/digital plan: accelerating AI adoption, expanding Global Delivery to improve fill rates, time-to-fill
- Strong track record of market share gains; relative revenue growth, reported, +850 bps since introduction of Simplify-Execute-Grow (Q3 22), and +290 bps YTD
Denis Machuel, Adecco Group CEO, commented:
“We continue to successfully deliver on our Simplify, Execute, Grow plan and third quarter performance was robust, against a high comparison base. The macroeconomic environment remains challenging, but I am encouraged to see that volume trends have stabilised.
We made further G&A savings in the quarter, allowing us to lift the year-end run-rate. We have reprioritised our IT/digital plans to accelerate AI adoption, and to expand Global Delivery to our top 25 customers. This will boost recruiter productivity and improve fill rates and time-to-fill, supporting profitable growth. We remain focused on capturing market share, building on strong progress over the last two years, and have positioned resources to capture growth opportunities as the market recovers.”
Webcast Details | Investors & Analysts
Investor Relations
[email protected]
+41 (0)44 878 88 88
Logo – https://mma.prnewswire.com/media/2350635/The_Adecco_Group_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/the-adecco-group-q3-2024-results-302295866.html
Strategic launch to cater to the growing demand for luxury real estate across Asia-Pacific
HONG KONG, Nov. 5, 2024 /PRNewswire/ — DAMAC International, a global leader in luxury real estate, has officially opened its new office in Hong Kong, marking its third office in the Asia-Pacific (APAC) region. This expansion is part of DAMAC’s broader vision to strengthen its presence in one of the world’s fastest-growing regions, renowned for its rapid investment growth. The Hong Kong office is a strategic gateway to the APAC market. It allows DAMAC to better serve its expanding clientele by offering direct access to its prestigious properties in Dubai and other international locations, such as London and Miami.
The Hong Kong office will provide investors across the region access to personalised services, offering exclusive insights into DAMAC’s luxury residential towers, branded residences, and lifestyle communities. As demand from the APAC region continues to rise, DAMAC is poised to offer high-end real estate investment opportunities that cater to the needs of discerning clients.
Talking about the opening, Abbas Sajwani, Board Member, DAMAC International, stated: “This is yet another milestone in our expansion into the APAC region. The new office will allow us to be closer to our clientele. It is a testament to our belief in the region’s potential and commitment to providing top-tier investment opportunities in luxury development.”
By establishing this new office, DAMAC continues positioning itself as a leading player in the global real estate market. It further strengthens its ability to connect with clients to provide unparalleled luxury investment opportunities for long-term value.
About DAMAC International
DAMAC International has been at the forefront of the Middle East’s luxury real estate market since 2002, delivering award-winning residential, commercial and leisure properties across the region and internationally, including in the UAE, Saudi Arabia, Qatar, Jordan, Lebanon, Iraq, the Maldives, Canada, the United States, as well as the United Kingdom.
Since then, the company has delivered more than 47,000 homes with over 40,000 more in diverse planning and development phases. Joining forces with some of the world’s most eminent fashion and lifestyle brands to create tremendous living experiences, such as with Versace, Roberto Cavalli, or de GRISOGONO. With a consistent vision and momentum, DAMAC is building the next generation of luxury living across the globe.
Live the Luxury.
Visit us at www.damacgroup.com
Photo: https://mma.prnewswire.com/media/2548365/DAMAC_International_Hong_Kong.jpg
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/damac-international-expands-presence-in-apac-with-new-office-in-hong-kong-302295571.html
-
Fintech4 days agoFintech Pulse: Your Daily Industry Brief – Breaking Trends and Insights in Fintech
-
Fintech6 days agoFintech Pulse: A Snapshot of Global Expansion, Regulatory Moves, and Transformative Tech in Fintech
-
Fintech PR6 days agoThe Rise of Insurance Third Party Administrator Market: A $544.67 Billion Industry Dominated by Tech Giants – Sedgwick, Crawford and Company and CorVel Corp | The Insight Partners
-
Fintech PR6 days agoMinisters and Global Executives to Converge at the Second Edition of Gateway Gulf in Bahrain
-
Fintech PR3 days agoCCTV+: From Silk Road Gateway to Global Innovation Hub: Xi’an Advances Industrial Upgrades and International Cooperation
-
Fintech PR4 days agoXinhua Silk Road: Financial co-op for global common dev’t under spotlight at forum held in E. China’s Shanghai Jing’an
-
Fintech PR4 days agoHitting Milestones, Coinstar and BBC Children in Need Celebrate Together with £1.6 Million in Donations
-
Fintech PR5 days agoAker Solutions ASA: Proposed extraordinary cash dividend of NOK 21 per share, in total NOK 10 billion